Infectious Disease Diagnostics Market Analysis and Forecast to 2031: By Product & Service (Assays, Kits & Reagents, Instruments, Services & Software), Technology (Immunodiagnostics, Clinical Microbiology, Polymerase Chain Reaction, Isothermal Nucleic Acid

Infectious Disease Diagnostics Market Analysis and Forecast to 2031: By Product & Service (Assays, Kits & Reagents, Instruments, Services & Software), Technology (Immunodiagnostics, Clinical Microbiology, Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next Generation Sequencing, DNA Microarray, Others), Diseases Type (Hepatitis, Human Immunodeficiency Virus, Chlamydia Trachomatis Genital Infection & Gonorrhea, Hospital Acquired Infections, Human Papillomavirus, Tuberculosis, Influenza, Others), End Use (Hospitals/Clinical Laboratories, Reference Laboratories, Others), and Region

The infectious diseases diagnostics market was valued at USD 35.5 billion in 2021 and it is anticipated to grow further up to USD 30.9 billion by 2031, at a CAGR of -1.4% during the forecast period.


A contagious illness A diagnostic is a laboratory test carried out by trained technicians and medical professionals to identify infectious diseases. It is a diagnostic process used to characterize and identify the infectious disease's causal organism. By using a variety of diagnostic techniques and tools, the sample of urine, blood, mucus, or other body fluids is examined to provide details on the causative organism.

Market Trends and Drivers

The market for infectious disease diagnostics will rise as a result of the prevalence of infectious diseases in both developed and emerging nations. The growing number of prescriptions for infectious illness diagnostic tests is due to the diagnosis and treatment of such disorders. The demand for infectious disease diagnostics is anticipated to increase during the projected period as a result of these factors and the expanding trend toward preventive medicine. The extensive population-based testing is necessary to enhance COVID-19 preventive and control activities. Since infectious disease diagnostics performs these tests, it had a favorable effect on this market.


Similarly, Major participants in the infectious illness diagnostics market are anticipated to have chances for expansion in emerging economies like India, South Korea, Brazil, and Mexico. This can be linked to the high disease prevalence, sizable patient population, expanding medical tourism, improving healthcare infrastructure, and rising disposable income in these nations. The Asia Pacific region has become a flexible and business-friendly hub because to fewer onerous rules and data requirements than the previously mentioned criteria.

Market Restraints and Challenges

One of the main factors limiting the growth of the infectious illness diagnostics industry is inadequate reimbursement. Getting health insurance to pay for the tests is a significant obstacle that the majority of diagnostic companies confront when trying to commercialize their tests.

Global Infectious Disease Diagnostics Market Segmental Overview

The report analyses the global infectious diseases diagnostics market based on the products & services, technology, disease type, end-use, and region.

Global Infectious Disease Diagnostics Market by Products & Services

Based on the products & services, it is segmented into assays, kits & reagents, instruments, services & software. The assays, kits & reagents segment is anticipated to dominate the market during the forecast period. Due to an increase in research and development (R&D) activities in the pharmaceutical and biotechnology industries, a rise in reagent demand, and a surge in the use of point-of-care testing. However, the instruments market is anticipated to expand significantly over the course of the forecast period due to an increase in research laboratories and increased funding from public and commercial organizations for the creation of diagnostic tools for the pharmaceutical and biotechnology sectors.

Global Infectious Disease Diagnostics Market by Technology

Based on the technology, it is segmented into immunodiagnostics, clinical microbiology, polymerase chain reaction, isothermal nucleic acid amplification technology, DNA sequencing & next generation sequencing, DNA Microarray, and others. The polymerase chain reaction segment is anticipated to dominate the market during the forecast period. Mostly as a result of the coronavirus pandemic's rapid spread. Since the COVID-19 outbreak, the use of reverse transcription polymerase chain reaction (RT-PCR) diagnostic testing has rapidly increased around the world. The pandemic's ongoing nature and the appearance of new variations indicate that need for PCR diagnostic solutions will persist in the ensuing years.

Global Infectious Disease Diagnostics Market by Disease Type

Based on the disease type, it is segmented into hepatitis, human immunodeficiency virus, chlamydia trachomatis genital infection and gonorrhea, hospital-acquired infection, human papillomavirus, tuberculosis, influenza, and others. The hepatitis segment is anticipated to dominate the market during the forecast period. Growing numbers of blood donors and transfusions are a major contributing factor to the illness, which can be treated if detected early. The senior population's high susceptibility and rising public awareness of hepatitis will continue to fuel demand for hepatitis diagnostic tools.

Global Infectious Disease Diagnostics Market by End User

Based on the end user, it is segmented into hospitals/clinical laboratories, reference laboratories, and others. The hospitals/clinical laboratories segment is likely to dominate the market during the forecast period. The key factors such as rising technological advancements in infectious disease diagnostics coupled with a shift in focus from centralized laboratories to decentralize POC testing are boosting the growth of the market.

Geographical Analysis of the Global Infectious Disease Diagnostics Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America is anticipated to dominate the market during the forecast period. Government and healthcare organizations are investing more on infrastructure, upgrades, and the need to deal with the growing burden of infectious diseases. Numerous initiatives have been done by the regional governments to increase the accessibility of diagnostic services. A better regulatory environment that requires infectious disease testing will improve the prognosis for the region.

Major Players in the Global Infectious Disease Diagnostics Market COVID-19 Impact

The new coronavirus is the infectious disease known as COVID-19. Before the outbreak started in Wuhan, China, in December 2019, COVID-19 was largely unknown. In just a few weeks, it went from a local issue to a worldwide pandemic. On March 11, 2020, the World Health Organization (WHO) designated COVID-19 to be a pandemic. Government agencies from all over the world are assisting laboratories in expediting COVID-19 testing procedures because testing is still an essential step in slowing the disease's rapid spread. Due to the employment of infectious disease diagnostic techniques for COVID-19 testing, the COVID-19 pandemic had a beneficial influence on the market for infectious illness diagnostics but had a negative impact on total sales for the majority of the companies.


Accordingly, regulatory agencies used techniques to hasten the licensing of COVID-19 diagnostic products. As diagnostic testing continues to be the foundation of the COVID-19 response, supporting containment efforts to reduce the outbreak, significant companies have also made strategic developments to deploy COVID-19 quick tests and neutralize the influence of COVID-19 on their operating capabilities. Additionally, due to the severity of the crisis and growing capacity problems with PCR-based testing, diagnostic solutions were developed more quickly to fulfill the demand for mass testing. Major players in this industry expanded their operations to test and monitor COVID-19.

Recent Developments

• November 2021, Roche Diagnostics launched Cobas 5800 system.
• February 2021, Thermo Fisher Scientific acquired Mesa Biotech (US) to expand the benefits of molecular diagnostics at the point of care.
• March 2020, Abbott Laboratories launched the ID NOW COVID-19 Test.

Frequently Asked Questions

Q1. How big is the Infectious Disease Diagnostics market?Ans. The global Infectious Disease Diagnostics market size was USD 35.5 Billion in 2021 and is anticipated to reach USD 30.9 Billion in 2031, growing at a rate of -1.4% from 2022 to 2031.
Q2. What is the Infectious Disease Diagnostics market growth rate?Ans. The growth rate of the Infectious Disease Diagnostics market is -1.4%.
Q3. Which region holds a major market share for the Infectious Disease Diagnostics market?Ans. North America holds a major market share of the Infectious Disease Diagnostics market in 2021.
Q4. Which segment accounted for the largest Infectious Disease Diagnostics market share?Ans. By end user, hospital/clinical laboratories segment accounted for the largest Infectious Disease Diagnostics market share.
Q5. Who are the key players in the Infectious Disease Diagnostics market?
Q6. What are the factors driving the Infectious Disease Diagnostics market growth?Ans. The major factors driving the growth of the market are the growing healthcare market in emerging countries.
Q7. What are the key growth strategies of Infectious Disease Diagnostics market players?Ans. The key growth strategies of Infectious Disease Diagnostics market players are product launch and product approval.
Q8. Which region will provide more business opportunities for the Infectious Disease Diagnostics market during the forecast period?Ans. The Asia-Pacific region will provide more business opportunities for the Infectious Disease Diagnostics market during the forecast period.

Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.